Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib. (Q43248494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

metastatic renal cell carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ludovic Trinquart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Daniel Balvay

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Charles A. Cuenod

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Clarisse Dromain

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

R Thiam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

J Medioni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

G Chatellier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

B Escudier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

S Oudard

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

4 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

936-941

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889607%20AND%20SRC:MED&resulttype=core&format=json

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Sunitinib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Treatment options in renal cell carcinoma: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Evaluation of lymph nodes with RECIST 1.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Validation of novel imaging methodologies for use as cancer clinical trial end-points

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Functional MRI for anticancer therapy assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Imaging tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

We should desist using RECIST, at least in GIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Reproducibility of linear tumor measurements using PACS: comparison of caliper method with edge-tracing method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466

Spiral CT of pulmonary nodules: interobserver variation in assessment of lesion size

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP466